High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation

High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation: safety and acute procedural outcome

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Paroxysmal Atrial Fibrillation Arrhythmias, Cardiac Atrial Fibrillation Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Deutsches Herzzentrum München

München, 80636, Germany

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

symptomatic, documented, drug-resistent paroxysmal atrial fibrillation
effective oral anticoagulation

Exclusion criteria

any prior left atrial ablation procedure
presence of left atrial thrombus
secondary atrial fibrillation due to electrolyte imbalance or thyroid disease
any prior oesophageal or gastric surgery

Treatment and study plan

High power short duration ablation

Procedure

Pulmonary vein isolation by high power short duration radiofrequency catheter ablation

Primary outcomes

Number of reconnected pulmonary veins 20 minutes after ablation in comparison of both ablation groups

Time frame: Acute endpoint

Secondary outcomes

Time to first documented recurrence of atrial fibrillation after a 6-week blanking period.

Time frame: 12 months after ablation

Sponsors and collaborators

Lead sponsor

Deutsches Herzzentrum Muenchen

Other

Registry information

Official study title

High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation: Safety and Acute Procedural Outcome

Important dates

Study start: 2019
Primary completion: 2023
Study completion: 2023
First posted: Jul 25, 2023
Registry last updated: Jul 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed